FA
BMY icon

Fedenia Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Fedenia Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7K Buy
+220
New +$12.6K ﹤0.01% 343
2025
Q1 		– Sell
-178
Closed -$10.1K – 150
2024
Q4 		$10.1K Buy
+178
New +$9.95K 0.01% 335

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Fedenia Advisers's BMY Position: Q2 2026 in Review

Fedenia Advisers opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 220 shares worth $12.7K. The stake represents ﹤0.01% of the portfolio and ranks #343 among its holdings. This is a return to the name: Fedenia Advisers previously reported a position in BMY as recently as Q4 2024.

Fedenia Advisers first reported a position in BMY in Q4 2024 and has held it in 2 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Fedenia Advisers held 220 shares of Bristol-Myers Squibb worth $12.7K as of Q2 2026.
  • Bristol-Myers Squibb was a new Fedenia Advisers position in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Fedenia Advisers's portfolio in Q2 2026, its #343 holding.
  • Fedenia Advisers first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 2 quarters since.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Fedenia Advisers's 13F filing for Q2 2026, filed 22 Jul 2026.